A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
PSA grassroots draft scripts for email and phone conversations
Draft email
Dear Mr/Ms XXX,
We know our health system has faced immense pressure over recent years. Pharmacists are too often overlooked and undervalued, despite the...
Spending on medicines rises even as dispensing drops
Australian prescription dispensing volume is lower, but spending on PBS medicines has increased in the past two years, according to the Australian Institute of...
Anticonvulsants shown not to provide low back pain benefits
Despite an increase in anticonvulsant use for back and neck pain recently - an increase of 535% in the last 10 years - researchers...
Collaborative prescribing to improve patient outcomes
The results of a study examining collaborative prescribing in Australian hospitals indicates that the practice, already successfully trialled in the US and the UK,...
From the President: Onboard with aged care
Earlier this year the outgoing Federal Health Minister Greg Hunt announced the government would allocate $345.7 million in the 2022–23 federal Budget for pharmacists in aged care.
Pharmacist Insight – Older and Wiser
Dr Renly Lim is a Research Fellow at the University of South Australia working to expand the role of pharmacists in residential care facilities,...
